HUP0300730A2 - Eljárás instabil angina pectoris kezelésére - Google Patents

Eljárás instabil angina pectoris kezelésére

Info

Publication number
HUP0300730A2
HUP0300730A2 HU0300730A HUP0300730A HUP0300730A2 HU P0300730 A2 HUP0300730 A2 HU P0300730A2 HU 0300730 A HU0300730 A HU 0300730A HU P0300730 A HUP0300730 A HU P0300730A HU P0300730 A2 HUP0300730 A2 HU P0300730A2
Authority
HU
Hungary
Prior art keywords
angina pectoris
unstable angina
treating unstable
treating
endothelinal
Prior art date
Application number
HU0300730A
Other languages
English (en)
Inventor
Peter Lerch
Thomas F. Lüscher
Georg Noll
Original Assignee
Zlb Bioplasma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zlb Bioplasma Ag filed Critical Zlb Bioplasma Ag
Publication of HUP0300730A2 publication Critical patent/HUP0300730A2/hu
Publication of HUP0300730A3 publication Critical patent/HUP0300730A3/hu
Publication of HU230151B1 publication Critical patent/HU230151B1/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pretreatment Of Seeds And Plants (AREA)
  • Flanged Joints, Insulating Joints, And Other Joints (AREA)
  • Supports For Pipes And Cables (AREA)
  • External Artificial Organs (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

A találmány rekonstituált nagy sűrűségű lipoprotein (rHDL)alkalmazására vonatkozik, mely alkalmazással magas koleszterinszintesetén javítható az endothelinilis funkció és gyógyíthatók vagymegelőzhetők az akut koszorúér-betegségek, mint amilyen az instabilangina pektoris vagy a miokardiális infarktus. Ó
HU0300730A 2000-07-20 2001-07-20 Rekonstituált HDL alkalmazása érrendszeri betegségek javítására használható gyógyszerkészítmények előállításában HU230151B1 (hu)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10035352A DE10035352A1 (de) 2000-07-20 2000-07-20 Verfahren zur Behandlung von instabiler Angina pectoris
DE10035352.5 2000-07-20
PCT/EP2001/008425 WO2002007753A2 (de) 2000-07-20 2001-07-20 Verfahren zur behandlung von instabiler angina pectoris

Publications (3)

Publication Number Publication Date
HUP0300730A2 true HUP0300730A2 (hu) 2003-12-29
HUP0300730A3 HUP0300730A3 (en) 2010-07-28
HU230151B1 HU230151B1 (hu) 2015-09-28

Family

ID=7649620

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0300730A HU230151B1 (hu) 2000-07-20 2001-07-20 Rekonstituált HDL alkalmazása érrendszeri betegségek javítására használható gyógyszerkészítmények előállításában

Country Status (17)

Country Link
US (1) US7053049B2 (hu)
EP (1) EP1303294B1 (hu)
JP (1) JP4928047B2 (hu)
KR (2) KR20070108955A (hu)
AT (1) ATE333887T1 (hu)
AU (2) AU2001282004B2 (hu)
CA (1) CA2418238C (hu)
DE (2) DE10035352A1 (hu)
DK (1) DK1303294T3 (hu)
ES (1) ES2266234T3 (hu)
HU (1) HU230151B1 (hu)
IL (2) IL154006A0 (hu)
NO (1) NO329848B1 (hu)
NZ (1) NZ523784A (hu)
PL (1) PL204406B1 (hu)
WO (1) WO2002007753A2 (hu)
ZA (1) ZA200300509B (hu)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007000924A1 (ja) * 2005-06-28 2007-01-04 Osaka University プログラニュリン活性を抑制または促進する物質を含む医薬組成物、およびプログラニュリン活性を抑制または促進する物質のスクリーニング方法
US7956035B2 (en) * 2007-03-01 2011-06-07 Csl Limited Treatment of endothelial dysfunction in diabetic patients
US20090110739A1 (en) * 2007-05-15 2009-04-30 University Of North Texas Health Science Center At Forth Worth Targeted cancer chemotherapy using synthetic nanoparticles
US8734853B2 (en) 2008-11-17 2014-05-27 University Of North Texas Health Science Center At Fort Worth HDL particles for delivery of nucleic acids
US9268023B2 (en) 2012-09-25 2016-02-23 Hewlett-Packard Development Company, L.P. Drop detection
ITMI20131300A1 (it) * 2013-08-01 2015-02-02 Nobil Bio Ricerche Srl Composizione per il riempimento di difetti ossei e parodontali
US9763892B2 (en) 2015-06-01 2017-09-19 Autotelic Llc Immediate release phospholipid-coated therapeutic agent nanoparticles and related methods
GB2603950A (en) 2021-02-22 2022-08-24 Reckitt & Colman Overseas Hygiene Home Ltd Effervescent germicidal compositions

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5128318A (en) * 1987-05-20 1992-07-07 The Rogosin Institute Reconstituted HDL particles and uses thereof
CA1335077C (en) * 1988-02-08 1995-04-04 Henri Isliker Process for the manufacture of apolipoproteins from human blood plasma or serum
EP0543417A1 (en) * 1991-11-22 1993-05-26 Lipogenics, Incorporated Tocotrienols and tocotrienol-like compounds and methods for their use
US5652339A (en) * 1993-12-31 1997-07-29 Rotkreuzstiftung Zentrallaboratorium Method of producing reconstituted lipoproteins
JPH10218861A (ja) * 1997-02-04 1998-08-18 Yamanouchi Pharmaceut Co Ltd 新規なフェネタノール誘導体又はその塩
US6140342A (en) * 1998-09-17 2000-10-31 Pfizer Inc. Oxy substituted 4-carboxyamino-2-methyl-1,2,3,4-tetrahydroquinolines
GB9919713D0 (en) * 1999-08-19 1999-10-20 Queen Mary & Westfield College New medical use of high density lipoprotein
AU777788B2 (en) * 1999-11-26 2004-10-28 Heart Research Institute Limited, The Oxidized apolipoproteins and methods of use
AUPQ429399A0 (en) 1999-11-26 1999-12-23 Heart Research Institute, The Oxidized apolipoproteins and methods of use

Also Published As

Publication number Publication date
ES2266234T3 (es) 2007-03-01
AU2001282004B2 (en) 2006-02-02
PL366395A1 (en) 2005-01-24
EP1303294B1 (de) 2006-07-26
NZ523784A (en) 2004-06-25
HUP0300730A3 (en) 2010-07-28
ATE333887T1 (de) 2006-08-15
NO329848B1 (no) 2011-01-10
KR100864079B1 (ko) 2008-10-16
JP4928047B2 (ja) 2012-05-09
DE50110552D1 (de) 2006-09-07
HU230151B1 (hu) 2015-09-28
AU8200401A (en) 2002-02-05
CA2418238A1 (en) 2003-01-16
NO20030137D0 (no) 2003-01-10
EP1303294A2 (de) 2003-04-23
US7053049B2 (en) 2006-05-30
CA2418238C (en) 2012-06-05
ZA200300509B (en) 2004-02-17
WO2002007753A2 (de) 2002-01-31
JP2004504355A (ja) 2004-02-12
KR20030026980A (ko) 2003-04-03
KR20070108955A (ko) 2007-11-13
DK1303294T3 (da) 2006-10-30
US20040014654A1 (en) 2004-01-22
DE10035352A1 (de) 2002-01-31
WO2002007753A3 (de) 2003-02-13
PL204406B1 (pl) 2010-01-29
IL154006A0 (en) 2003-07-31
IL154006A (en) 2010-05-31
NO20030137L (no) 2003-01-10

Similar Documents

Publication Publication Date Title
CY1106180T1 (el) Σκευασματα διασπορας τα οποια πepιεχουν αναστολεις λιπασης
BR9908280A (pt) Inibidores de enzimas de fosfolipase
ATE263157T1 (de) Nematizide trifluorbutene
MY142948A (en) Benzophenones as inhibitors of reverse transcriptase
EA200501805A1 (ru) Фармацевтическая композиция, содержащая ингибитор фермента дипептидилпептидазы
DK1066056T4 (da) Jerndextranforbindelse til anvendelse som komponent i et terapeutisk middel til forebyggelse af eller behandling af jernmangel, fremgangsmåde til fremstilling af jerndextranforbindelsen og anvendelse af denne forbindelse til fremstilling af et...
PT1109571E (pt) Metodos de tratamento da hipertensao e composicoes para utilizacao nesses metodos
ATE486915T1 (de) Azeotrop-ähnliche zusammensetzung von 1,2-dichlor-3,3,3-trifluorpropen und fluorwasserstoff
HUP0300730A2 (hu) Eljárás instabil angina pectoris kezelésére
SE9604348D0 (sv) Användning av hydroxyguanidiner
DE69429816D1 (de) C1-Esterasehemmer zur Verringerung von Myokardschäden bei akutem Herzinfarkt
ES2088128T3 (es) Aminosulfonilureas inhibidoras de acat.
DE69808475D1 (de) Aminosäurederivate zur behandlung von schlaganfall
DE602005016697D1 (de) Molekulardiagnoseverfahren und behandlung von demenz mit lewy-körperchen
DE60219940D1 (de) Verwendung von irbesartan zur vorbeugung oder behandlung pulmonaler hypertonie
DK0996439T3 (da) Beta-alkoxyacrylater mod malaria
ATE440108T1 (de) Plasmin-inhibitoren von der australischen braunen schlange, pseudonaja textilis textilis
ATE286933T1 (de) Zugabe von behandlungsmitteln bei festphasenpolymerisationsverfahren
WO2005002505A3 (en) Apolipoprotein c-1 induced apoptosis
BR0013665A (pt) Uso de uma proteìna histacalina, composição farmacêutica, e, método de tratar ou impedir conjuntivite
ES2185154T3 (es) Metodo de uso de inhibidores de la ciclooxigenasa-2 en el tratamiento y prevencion de la demencia.
WO1999025327A3 (en) Small molecule intervention in hiv-1 replication
ATE317384T1 (de) Lta4 hydrolase-hemmer
DE60203726D1 (de) Topische zusammensetzung enthaltend brucin und ihre verwendung zur behandlung von hautschäden
UA32350A (uk) Спосіб лікування гострого інфаркту міокарда

Legal Events

Date Code Title Description
HC9A Change of name, address

Owner name: CSL BEHRING AG, CH

Free format text: FORMER OWNER(S): ZLB BIOPLASMA AG, CH; ZLB BEHRING AG, CH

MM4A Lapse of definitive patent protection due to non-payment of fees